Rhumbline Advisers boosted its stake in shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) by 12.9% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback